Max Healthcare and IIIT Delhi partner for healthcare research and education – Express Healthcare
The partnership aims to leverage the strengths of both organisations to promote and conduct high-quality research
Related Articles
Is Regulating Healthcare Costs Counterproductive? SC Order Opens Pandora’s Box
The Indian private healthcare sector, the largest in the world, has so far was seen as being largely unregulated.
Cook Medical launches Ascend single-use ureteroscope in U.S., Canada
Cook Medical this week announced it launched its Ascend Single-Use Flexible Ureteroscope in the U.S. and Canada.
MMI’s Symani surgical robot used in first U.S. clinical cases
MMI announced the reconstructive extremity microsurgeries a month after winning FDA de novo classification for its Symani surgical robot.
Healthcare organizations secure 50% more sensitive data than global average
The Rubrik Zero Labs research unit found that the average healthcare organization holds upwards of 42 million sensitive data records, 50% more than the global…
J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer – MedCity News
Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could…
CVS scoops up tech-enabled Medicare Advantage broker Hella Health
CVS has quietly acquired Hella Health, a startup Medicare Advantage (MA) broker based in New York City, according to a post on LinkedIn. | CVS…
How the virtual care market is shaking out in 2024 as Walmart, Optum exit the telehealth business
News this week that Walmart is shuttering all 51 health cen | Many digital health leaders say recent moves by Walmart and Optum to exit…
Hospitals still affected by Change hack, AHA says
Discover the ongoing financial and operational impacts hospitals are facing after the Change Healthcare hack, with claims and payment processing still affected.
Labcorp gains FDA approval for companion diagnostic to Pfizer gene therapy
The test would determine if patients are eligible for Pfizer’s new hemophilia B treatment by detecting if they have been exposed to a virus that…
Quest Diagnostics carves out PathAI’s digital pathology lab, plots AI ramp-up
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. | Quest…